Discover cutting-edge studies on carcinogenesis, biomarkers, and targeted therapeutic approaches
Discover how Gamitrinib, a first-in-class mitochondrial-targeted drug, selectively destroys cancer cells by exploiting their energy dependency while sparing healthy tissues.